Within first 100 days of prophylaxis
 
Probability of an invasive fungal infection (IFI)
 
Posaconazole

0.05

Cornely[10]

0.0344 0.0573

Assumption

Beta

0.0120

SAT

0.11

Cornely[10]

0.0825 0.1375

Assumption

Beta

0.0181

Probability of an IFIrelated death
 
Posaconazole

0.36

Cornely[10]

0.2678 0.4464

Assumption

Beta

0.1247

SAT

0.48

Cornely[10]

0.36360.6060

Assumption

Beta

0.0857

Probability of death from other causes (non IFIrelated)
 
Posaconazole

0.16

Cornely[10]

0.11850.1975

Assumption

Beta

0.0148

SAT

0.16

Cornely[10]

0.11850.1975

Assumption

Beta

0.0148

After first 100 days of prophylaxis
 
Relative survival associated with acute myelogenous leukaemia (AML)
 
IFI

0.21

NCI[32]

0.160.26

Assumption

Gamma

0.000

No IFI

0.21

NCI[32]

0.160.26

Assumption

Gamma

0.000

Relative survival associated with myelodysplastic syndrome (MDS)
 
IFI

0.08

Kantarjian[33]

0.060.10

Assumption

Gamma

0.000

No IFI

0.08

Kantarjian[33]

0.060.10

Assumption

Gamma

0.000
